The effect of miR-224 down-regulation on SW80 cell proliferation and apoptosis and weakening of ADM drug resistance.
Glycogen synthase kinase-3β (GSK-3β) can phosphorylate and degrade β-catenin, and negatively regulates Wnt/β-catenin signal pathway. MiR-224 up-regulation is associated with colorectal cancer (CRC). Bioinformatics analysis showed complementary binding sites between miR-224 and GSK-3β. This study investigated if miR-224 plays a role in mediating GSK-3β expression, Wnt/β-catenin pathway activity, CRC cell proliferation, apoptosis as well as drug sensitivity of Adriamycin (ADM). Dual luciferase gene reporter assay demonstrated the regulatory relationship between miR-224 and GSK-3β. Expression of miR-224, GSK-3β, β-catenin, and Survivin was measured in normal colon epithelium NCM460, CRC cell line SW480, and drug-resistant SW480/ADM cell line. Flow cytometry measured apoptosis under ADM with an IC50 concentration of SW480 cells, followed by CCK-8 analysis of cell proliferation. SW480/ADM cells were treated with miR-224 inhibitor and/or pSicoR-GSK-3β, followed by analysis of the expressions of GSK-3β, β-catenin and Survivin, cell apoptosis, and cell proliferation by EdU staining. MiR-224 targeted and inhibited GSK-3β expression. In SW480/ADM cells, GSK-3β expression and cell apoptosis rate were lower than those in SW480 cells, whilst miR-224, β-catenin, and Survivin expression or proliferation were higher than those in SW480 cells. Transfection of miR-224 inhibitor and/or pSicoR-GSK-3β significantly increased GSK-3β expression in SW480/ADM cells, and decreased β-catenin and Survivin expression, leading to reduced proliferation potency, enhanced cell apoptosis and suppressed ADM resistance. MiR-224 up-regulation is associated with ADM resistance of CRC cells. Suppression of miR-224 expression up-regulated GSK-3β expression, inhibited Wnt/β-catenin signal pathway activity and Survivin expression, as well as reduced ADM resistance of CRC SW480 cells.